|
|
|
|
|
|
|
|
|
|
Previous: DURA PHARMACEUTICALS INC, 10-K405/A, EX-10.38, 2000-08-01 |
Next: DURA PHARMACEUTICALS INC, 10-K405/A, EX-21, 2000-08-01 |
<PAGE>
EXHIBIT 11
DURA PHARMACEUTICALS, INC.
STATEMENTS RE COMPUTATIONS OF NET INCOME (LOSS) PER SHARE
<TABLE>
<CAPTION>
1999 1998 1997
NET INCOME PER SHARE - BASIC -------------- --------------- --------------
<S> <C> <C> <C>
Net income $ 30,004,000 $ 2,733,000 $ (84,692,000)
============== =============== ==============
Weighted average number of common shares:
Common stock 44,132,372 46,028,396 43,828,208
============== =============== ==============
Net income per share $ 0.68 $ 0.06 $ (1.93)
NET INCOME PER SHARE - DILUTED
Net income $ 30,004,000 $ 2,733,000 $ (84,692,000)
============== =============== ==============
Weighted average number of common and
common equivalent shares assuming
issuance of all dilutive contingent shares:
Common stock 44,132,372 46,028,396 43,828,208
Stock options 906,859 744,155 -
Warrants 633,070 1,036,440 -
-------------- -------------- --------------
Total 45,672,301 47,808,991 43,828,208
============== ============== ==============
Net income per share $ 0.66 $ 0.06 $ (1.93)
============== ============== ==============
</TABLE>
|
|